Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23165191)

1.

A comparison of the clinical features and prognosis of pancreatic head cancer with that of other periampullary cancers.

Liang YM, Wang T, Sun QL, Cheng YF.

Hepatogastroenterology. 2013 Jun;60(124):864-9. doi: 10.5754/hge12903. Epub 2012 Nov 20.

PMID:
23165191
2.

Information needs among patients and a surveillance strategy after surgery for pancreatic and periampullary cancer.

Labori KJ, Verbeke CS, Gladhaug IP.

HPB (Oxford). 2015 Jul;17(7):659. doi: 10.1111/hpb.12411. Epub 2015 Mar 16. No abstract available.

PMID:
25776256
3.

Diagnostic evaluation and staging of pancreatic ductal adenocarcinoma.

McIntyre CA, Winter JM.

Semin Oncol. 2015 Feb;42(1):19-27. doi: 10.1053/j.seminoncol.2014.12.003. Epub 2014 Dec 9. Review.

PMID:
25726049
4.

Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages.

Yu J, Blackford AL, Dal Molin M, Wolfgang CL, Goggins M.

Gut. 2015 Jan 30. pii: gutjnl-2014-308653. doi: 10.1136/gutjnl-2014-308653. [Epub ahead of print]

5.

Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma.

Zhou J, Song S, Li D, He S, Zhang B, Wang Z, Zhu X.

World J Surg Oncol. 2014 Mar 5;12:52. doi: 10.1186/1477-7819-12-52.

6.

Periampullary lymphoma masquerading as adenocarcinoma.

Lokesh KN, Lakshmaiah KC, Premalata CS, Lokanatha D.

Indian J Surg Oncol. 2013 Jun;4(2):155-7. doi: 10.1007/s13193-013-0237-8. Epub 2013 Mar 28. No abstract available.

7.

Negative impact of fresh-frozen plasma transfusion on prognosis of pancreatic ductal adenocarcinoma after pancreatic resection.

Shiba H, Misawa T, Fujiwara Y, Futagawa Y, Furukawa K, Haruki K, Iida T, Iwase R, Yanaga K.

Anticancer Res. 2013 Sep;33(9):4041-7.

PMID:
24023348
8.

Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.

Stotz M, Eisner F, Szkandera J, Absenger G, Kornprat P, Lackner C, Samonigg H, Gerger A, Pichler M.

J Clin Pathol. 2013 Sep;66(9):753-7. doi: 10.1136/jclinpath-2012-201394. Epub 2013 Jun 8.

PMID:
23750038
9.

A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.

Minagawa N, Sato N, Mori Y, Tamura T, Higure A, Yamaguchi K.

Eur J Surg Oncol. 2013 Jun;39(6):554-8. doi: 10.1016/j.ejso.2013.02.016. Epub 2013 Mar 15.

PMID:
23506840
10.

Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.

Nordby T, Hugenschmidt H, Fagerland MW, Ikdahl T, Buanes T, Labori KJ.

Eur J Surg Oncol. 2013 Jun;39(6):559-66. doi: 10.1016/j.ejso.2013.02.020. Epub 2013 Mar 14.

PMID:
23498362
11.

A and B blood group antigens in human pancreatic ductal adenocarcinomas.

Handra-Luca A.

Oncology. 2013;84(3):141-9. doi: 10.1159/000345028. Epub 2012 Dec 14.

PMID:
23257765
12.

[New S3 guidelines on exocrine pancreatic cancer].

Tannapfel A; Deutsche Abteilung der Internationalen Akademie für Pathologie, der Deutschen, der Österreichischen und der Sc.

Pathologe. 2012 Nov;33 Suppl 2:266-8. doi: 10.1007/s00292-012-1638-0. German.

PMID:
23011018
13.

Survival among pancreaticoduodenectomy patients treated for pancreatic head cancer <1 or 2 cm.

Franko J, Hugec V, Lopes TL, Goldman CD.

Ann Surg Oncol. 2013 Feb;20(2):357-61. doi: 10.1245/s10434-012-2621-y. Epub 2012 Sep 1.

PMID:
22941171
14.

Gastric- and intestinal-type marker expression in invasive ductal adenocarcinoma of the pancreas.

Takano Y, Ohike N, Tajiri T, Asonuma K, Harada K, Takahashi H, Morohoshi T.

Hepatobiliary Pancreat Dis Int. 2012 Aug 15;11(4):424-8.

15.

Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.

Nanashima A, Tobinaga S, Abo T, Hatano K, Takeshita H, Nonaka T, Hidaka S, Tanaka K, Kunizaki M, Sawai T, Yasutake T, Nagayasu T.

Hepatogastroenterology. 2012 May;59(115):911-5. doi: 10.5754/hge10038.

PMID:
22469741
16.
17.

Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.

Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM, White SA.

Eur J Surg Oncol. 2012 Apr;38(4):333-9. doi: 10.1016/j.ejso.2011.12.020. Epub 2012 Feb 7.

PMID:
22317758
18.

Clinicopathologic assessment of pancreatic ductal carcinoma located at the head of the pancreas, in relation to embryonic development.

Okamura Y, Fujii T, Kanzaki A, Yamada S, Sugimoto H, Nomoto S, Takeda S, Nakao A.

Pancreas. 2012 May;41(4):582-8. doi: 10.1097/MPA.0b013e318239d233.

PMID:
22228049
19.

Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.

Nakao A, Kanzaki A, Fujii T, Kodera Y, Yamada S, Sugimoto H, Nomoto S, Nakamura S, Morita S, Takeda S.

Ann Surg. 2012 Jan;255(1):103-8. doi: 10.1097/SLA.0b013e318237872e.

PMID:
22156923
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk